According to Soligenix's latest financial reports the company's total debt is $3.49 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $10.24 M | 2.79% |
2021-12-31 | $9.96 M | -5.18% |
2020-12-31 | $10.5 M | 8158% |
2019-12-31 | $0.12 M | |
2018-12-31 | $N/A | |
2016-12-31 | $N/A | -100% |
2015-12-31 | $0.29 M | -92.28% |
2014-12-31 | $3.78 M | -54.24% |
2013-12-31 | $8.28 M | |
2004-12-31 | $0.11 M | -67.71% |
2003-12-31 | $0.35 M | -50.81% |
2002-12-31 | $0.72 M | 236.63% |
2001-12-31 | $0.21 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 839,261.75% | ๐บ๐ธ USA |
Pfizer PFE | $70.84 B | 2,027,193.85% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | 582,723.02% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |
Athersys ATHX | $18.57 M | 431.60% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $20.15 B | 576,596.35% | ๐ฎ๐ฑ Israel |
Cleveland BioLabs
CBLI | N/A | N/A | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.86 B | 24,515.40% | ๐บ๐ธ USA |